Reporter
To continue getting breaking news and the full stories from The Boston Globe, subscribe today.

Weisman covers the healthcare and life sciences industries for the Business section. He was a business reporter and editor for the Hartford Courant and the Seattle Times before joining the Globe in 2000.
Year by year, the Globe 100 has chronicled the shifting dominance of local industries and the emergence of promising new ventures.
Earnings rose despite a state decision to drop an assessment on the insurer’s newly acquired health insurance division.
Biopharmaceutical companies Novartis AG and Amgen Inc. have signed on as limited partners in a new $265 million venture capital fund.
The drug, called Xofigo, treats castration-resistant prostate cancer, a disease that afflicts tens of thousands of men in the US.